The aim of this study was to determine whether the SULT1A1 rs9282861 genotype is associated with clinical outcome of patients diagnosed with early breast cancer and treated with either adjuvant TAM or chemotherapy. This evidence concerns the gene SULT1A1 and breast cancer.